Literature DB >> 33420986

Polyubiquitin Profile in Down Syndrome and Alzheimer's Disease Brain.

Antonella Tramutola1, Marzia Perluigi2.   

Abstract

Posttranslational modifications (PTMs) of a protein are chemical modifications that play a key role because they regulate almost all cellular events, including gene expression, signal transduction, protein-protein interaction, cell-cell interaction, and communication. Defects in PTMs have been linked to numerous developmental disorders and human diseases, highlighting the importance of PTMs in maintaining normal cellular states. PTMs reversibly or irreversibly alter the structure and properties of proteins through biochemical reactions, thus extending protein function beyond what is dictated by gene transcripts. As analytical approaches have evolved, the biological influences of many types of PTMs have been identified and are routinely analyzed in many systems.Among several types of PTMs, polyubiquitination-addition of ubiquitin (often in the form of polymers) to substrates-governs a variety of biological processes ranging from proteolysis to DNA damage response. The functional flexibility of this modification correlates with the existence of a large number of ubiquitinating enzymes that form distinct ubiquitin polymers, which in turn result in different signals. Thus, the need of specific and sensitive methods for the analysis of the complexity of ubiquitin chain linkage is needed to understand how this structural diversity could translate into various cellular functions. In this section, we described a detailed protocol to enrich polyubiquitinated proteins.

Entities:  

Keywords:  Alzheimer’s disease; Down syndrome; Polyubiquitination; Protein modification; Proteomics

Mesh:

Substances:

Year:  2021        PMID: 33420986     DOI: 10.1007/978-1-0716-1186-9_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

Review 1.  Regulatory functions of ubiquitination in the immune system.

Authors:  Yinon Ben-Neriah
Journal:  Nat Immunol       Date:  2002-01       Impact factor: 25.606

Review 2.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Authors:  Michael H Glickman; Aaron Ciechanover
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

Review 3.  A field guide to ubiquitylation.

Authors:  S Fang; A M Weissman
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

Review 4.  Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions.

Authors:  Koraljka Husnjak; Ivan Dikic
Journal:  Annu Rev Biochem       Date:  2012-04-05       Impact factor: 23.643

5.  K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody.

Authors:  Marissa L Matsumoto; Katherine E Wickliffe; Ken C Dong; Christine Yu; Ivan Bosanac; Daisy Bustos; Lilian Phu; Donald S Kirkpatrick; Sarah G Hymowitz; Michael Rape; Robert F Kelley; Vishva M Dixit
Journal:  Mol Cell       Date:  2010-07-22       Impact factor: 17.970

Review 6.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 7.  The spatial and temporal organization of ubiquitin networks.

Authors:  Caroline Grabbe; Koraljka Husnjak; Ivan Dikic
Journal:  Nat Rev Mol Cell Biol       Date:  2011-03-30       Impact factor: 94.444

8.  The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease.

Authors:  Yasuo Ihara; Maho Morishima-Kawashima; Ralph Nixon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation.

Authors:  Ping Xu; Duc M Duong; Nicholas T Seyfried; Dongmei Cheng; Yang Xie; Jessica Robert; John Rush; Mark Hochstrasser; Daniel Finley; Junmin Peng
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

10.  cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4).

Authors:  Mathieu J M Bertrand; Saskia Lippens; An Staes; Barbara Gilbert; Ria Roelandt; Jelle De Medts; Kris Gevaert; Wim Declercq; Peter Vandenabeele
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

View more
  1 in total

Review 1.  Ubiquitin carboxyl-terminal hydrolase L-1 in brain: Focus on its oxidative/nitrosative modification and role in brains of subjects with Alzheimer disease and mild cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2021-11-01       Impact factor: 7.376

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.